Keywords
Propofol
Near-infrared brain function imaging
Cerebral hemodynamics
Submitted : 2025-08-09
Accepted : 2025-08-24
Published : 2025-09-08
Abstract
Objective: To investigate the characteristics and significance of near-infrared brain function imaging in patients with depressive disorder after administration of propofol injection. Methods: A total of 28 subjects with depressive disorder diagnosed according to DSM-5 criteria were selected from Xi’an Mental Health Center between January 2022 and January 2025. They were randomly divided into an experimental group (propofol group, n=14) and a control group (intralipid group, n=14) using a random number table. Changes in integral value (IV) and centroid value (CV) before and after treatment were measured using near-infrared brain function imaging. Results: No significant difference was observed in HAMD scores between the two groups 24 hours before treatment (P > 0.05). Repeated-measures ANOVA revealed significant effects of time (Ftime = 32.237, Ptime < 0.001), group (Fgroup = 47.027, Pgroup < 0.001), and their interaction (Finteraction = 31.829, Pinteraction < 0.001). The integral values in the frontal and temporal regions were significantly higher in the experimental group than in the control group (P < 0.05). However, no significant differences were found in the centroid values of the frontal or temporal regions between the two groups (P > 0.05). Conclusion: Near-infrared brain function imaging detected specific acute hemodynamic changes in the prefrontal and temporal regions of patients with depressive disorder after propofol intervention. These changes may be related to the mechanism of action of propofol. However, this study did not confirm a direct linear correlation between changes in integral/centroid values and the degree of clinical improvement in depressive symptoms. Propofol intervention combined with deep anesthesia rapidly improved depressive symptoms and was accompanied by enhanced hemodynamic activity in the prefrontal/temporal regions, though its specificity requires further validation.
References
Huang P, Wang K, Zhang X, et al., 2025, Research Progress on Magnetic Resonance Imaging and Neurobiological Mechanisms of Anhedonia in Major Depressive Disorder. Chinese Journal of Neurology and Psychiatry, 51(3): 180–185.
Shi J, Han X, Liao Y, et al., 2023, Associations of Stressful Life Events With Subthreshold Depressive Symptoms and Major Depressive Disorder: The Moderating Role of Gender. Journal of Affective Disorders, 325: 588–595.
Lybbert C, Huang J, Jones K, et al., 2023, Clinical Validation of an Adapted Eleveld Model for High-Dose Propofol Treatments for Depression. Journal of Clinical Monitoring and Computing, 37(5): 1369–1377.
Tak S, Ye J, 2014, Statistical Analysis of fNIRS Data: A Comprehensive Review. Neuroimage, 85: 72–91.
Jia H, Yang Y, Cui L, 2025, Differences in Levels of Inflammatory Cytokines in Peripheral Blood Between Adolescents With Unipolar and Bipolar Depressive Disorders. Chinese Journal of Neurology and Psychiatry, 51(5): 286–292.
Piper S, Li J, Lu W, et al., 2014, A Toolbox for the Analysis of Near-Infrared Spectroscopy Data. Neurophotonics, 1(2): 020801.
Zhao Z, 2025, Research Progress on the Central Anesthetic Mechanism of Propofol. Northern Pharmacology, 22(3): 191–192, 196.
Yan Y, Ma H, Zhao J, 2023, Propofol Brings New Light to Depression Therapy. Neuroscience Bulletin, 39(12): 1891–1894.
Kabra A, Garg R, Brimson J, et al., 2022, Mechanistic Insights Into the Role of Plant Polyphenols and Their Nano-Formulations in the Management of Depression. Frontiers in Pharmacology, 13: 1046599.
Zhang H, Bian Y, Wang G, et al., 2022, Functional Near-Infrared Spectroscopy Imaging Study of Drug Intervention in Patients With Depression. Advances in Psychology, 12(9): 3284–3292.